Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 153   

Articles published

NVS 99.80 +1.28 (1.30%)
price chart
Stock To Watch : Novartis AG (ADR)(NYSE:NVS)
Novartis AG (ADR)(NYSE:NVS) (TREND ANALYSIS) shares are still trading near the 52-week high of $102.59. The stock closed last trading session at $101.48, with a volume of 1,334,174 shares against an average volume for the last 3 months of 1,498,780.
Novartis AG (ADR) Expects Higher Profit Margin & Dividends This Year
Novartis AG (ADR) (NYSE:NVS) expects its profit margin to increase in 2015 on the back of a restructured drug portfolio and cost-cutting measures.
Pre-Market Stocks Roundup: Novartis AG (ADR) (NYSE:NVS), Rackspace ...
Novartis declared one-year study results from the MEASURE 2 pivotal Phase III study of investigational secukinumab in ankylosing spondylitis (AS).
Gender Discrimination Lawsuit Filed Against Novartis AG (ADR)(NYSE:NVS)
There are various allegations of Sexual discrimination against Novartis AG (ADR) (NYSE:NVS)and it will have to defend itself against them in US courts.
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS), Sanofi SA (ADR ...
The stocks include London-based GlaxoSmithKline plc (ADR) (NYSE:GSK), Switzerland-based Novartis AG (ADR) (NYSE:NVS) and France-based Sanofi SA (ADR) (NYSE:SNY).
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Unveils Big Business Growth Targets  WallStreetPR (blog)
GlaxoSmithKline scraps HIV spinout, reports higher Q1 profit  Proactive Investors USA & Canada
Here's Why Novartis AG (ADR) Is Expected To See Soaring Top-Line Growth
Novartis AG (ADR) (NYSE:NVS) has seen its product sales suffer considerably since 2011 on the back of a patent cliff that hit the company's more than a decade-long blockbuster drug Diovan.
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Novartis AG (ADR) (NYSE:NVS) announced on Monday that the two companies have completed a series of complicated asset swaps worth $20 billion, in what appears to be a move to tidy up asset portfolios to ...
Asset Swaps Of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline plc (ADR ...
GSK deal's done. Now, Novartis has to deliver on cancer-growth pledge  FiercePharma
Pharma's Record Setting First Quarter [Actavis plc, Allergan, Inc., Eli Lilly ...
Some major deals have contributed to that record-breaking total. In March, AbbVie Inc. (NYSE: ABBV) announced the purchase of Pharmacyclics Inc.(Nasdaq: PCYC) for $21 billion.
Novartis AG (ADR) (NVS) Delisting Rumors Of Its $419 Million Indian Arm Denied
Novartis AG (NYSE:NVS) is considering to delist its Indian operations, according to Bloomberg, which cited people close to the matter.
Novartis AG (ADR) (NVS) And Juno Therapeutics Inc (JUNO) Reach Mutual ...
Novartis AG (ADR) (NYSE:NVS) and Juno Therapeutics Inc (NASDAQ:JUNO) have reached a settlement to their long-running patent war.
Novartis AG (ADR) To Pay $12.3 Million To Juno In CAR-T Patent Settlement  Bidness ETC